NorthRock Partners LLC Buys New Stake in Omega Healthcare Investors, Inc. $OHI

NorthRock Partners LLC bought a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) during the 2nd quarter, HoldingsChannel reports. The fund bought 5,844 shares of the real estate investment trust’s stock, valued at approximately $214,000.

Several other large investors have also recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB boosted its stake in Omega Healthcare Investors by 562.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 1,552 shares in the last quarter. Register Financial Advisors LLC bought a new position in Omega Healthcare Investors during the 2nd quarter valued at $73,000. Trust Co. of Vermont bought a new position in Omega Healthcare Investors during the 2nd quarter valued at $95,000. Meeder Asset Management Inc. boosted its stake in Omega Healthcare Investors by 1,581.3% during the 1st quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust’s stock valued at $96,000 after purchasing an additional 2,372 shares in the last quarter. Finally, UMB Bank n.a. boosted its stake in Omega Healthcare Investors by 22.9% during the 2nd quarter. UMB Bank n.a. now owns 2,672 shares of the real estate investment trust’s stock valued at $98,000 after purchasing an additional 497 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

OHI has been the subject of a number of research reports. Scotiabank increased their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research note on Thursday, August 28th. Raymond James Financial reaffirmed an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Mizuho raised their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, September 11th. Cantor Fitzgerald started coverage on Omega Healthcare Investors in a research note on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective for the company. Finally, Wells Fargo & Company raised their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 27th. Six investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Omega Healthcare Investors currently has a consensus rating of “Moderate Buy” and a consensus price target of $44.38.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

Omega Healthcare Investors Price Performance

NYSE OHI opened at $41.07 on Friday. The firm has a market cap of $12.12 billion, a P/E ratio of 25.35, a price-to-earnings-growth ratio of 1.89 and a beta of 0.70. The stock’s 50-day moving average is $41.58 and its two-hundred day moving average is $38.88. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.04 and a fifty-two week high of $44.42. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same period last year, the business posted $0.71 earnings per share. The firm’s revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.5%. Omega Healthcare Investors’s payout ratio is 165.43%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.